Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12005097 Aflibercept formulations and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Alison J. Gillespie0

Julee A. Floyd0

Bruce A. Kerwin0

Christine C Siska0

Date of Patent

June 11, 2024

0

Patent Application Number

174926490

Date Filed

October 3, 2021

0

Patent Citations

US Patent 7303747 Use of VEGF inhibitors for treatment of eye disorders

0

US Patent 7306799 Use of VEGF inhibitors for treatment of eye disorders

0

US Patent 7374757 Modified chimeric polypeptides with improved pharmacokinetic properties

0

US Patent 7374758 Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof

0

US Patent 7521049 Use of VEGF inhibitors for treatment of eye disorders

0

US Patent 7524499 Modified chimeric polypeptides with improved pharmacokinetic properties

0

US Patent 8029791 Modified chimeric polypeptides with improved pharmacokinetic properties

0

US Patent 8092803 VEGF antagonist formulations for intravitreal administration

0

...

Patent Primary Examiner

Christine J. Saoud

0

Patent abstract

Ophthalmic formulations comprising aflibercept are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12005097 Aflibercept formulations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool